| WAM Active Limited (WAA) ORDINARY FULLY PAID |
Financials |
$151 |
Appendix 4G
|
26 Aug 2025 9:41AM |
$0.890 |
$1.020 |
risen by
14.61%
|
|
| Vaughan Nelson Global SMID Fund (Managed Fund) (VNGS) |
Financials |
$51 |
Disclosure of Portfolio Holdings - June 2025
|
26 Aug 2025 9:41AM |
$3.560 |
$3.920 |
risen by
10.11%
|
|
| Evergold Minerals Limited (EG1) ORDINARY FULLY PAID |
Materials |
$10 |
EG1 acquires Queens and Mt Monger Gold Projects in WA
|
26 Aug 2025 9:41AM |
$0.035 |
$0.024 |
fallen by
31.43%
|
|
EG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Evergreen Lithium Limited (EG1) has acquired the Queens and Mt Monger Gold Projects in Western Australia.
- The acquisition is intended to diversify EG1’s mineral portfolio with prospective gold assets.
- Queens Project is located in the Yalgoo-Singleton greenstone belt, an area known for gold mineralization.
- Mt Monger Project is in the Eastern Goldfields, historically a prolific gold-producing region.
- EG1 plans to undertake exploration activities such as soil sampling, mapping, and drilling.
- The company is primarily focused on lithium but sees gold as a complementary asset class.
- Management believes these acquisitions enhance EG1’s exposure to precious metals and provide opportunities for exploration success.
- The transactions are expected to deliver value creation for EG1 shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$44 |
Appendix 4G and Corporate Governance Statement
|
26 Aug 2025 9:41AM |
$0.150 |
$0.058 |
fallen by
61.33%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$25 |
KME FY2025 Full Year Results Media Release
|
26 Aug 2025 9:40AM |
$0.605 |
$0.470 |
fallen by
22.31%
|
|
KME - Price-sensitive ASX Announcement
Full Release
Key Points
- KME achieved record total revenue and growth in student numbers for FY2025.
- Both franchise and company-owned centre revenues increased.
- Continued expansion in the UK and Australian markets.
- Significant investment in digital platforms and technology enhanced operational efficiency.
- Online student enrollments showed notable growth.
- The company demonstrated resilience despite economic challenges and rising costs.
- Focus on high-quality education and flexible learning solutions.
- Strong balance sheet supports ongoing investments in growth initiatives.
- Positive outlook for future growth with planned centre openings and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Loomis Sayles Global Equity Fund (Quoted Managed Fund) (LSGE) |
Financials |
$39 |
Disclosure of Portfolio Holdings - June 2025
|
26 Aug 2025 9:40AM |
$2.430 |
$2.080 |
fallen by
14.40%
|
|
| WhiteHawk Limited (WHK) ORDINARY FULLY PAID |
Information Technology |
$5 |
WHK Chief Strategy Officer Designation & Contract Updates
|
26 Aug 2025 9:39AM |
$0.010 |
$0.004 |
fallen by
60%
|
|
WHK - Price-sensitive ASX Announcement
Full Release
Key Points
- WhiteHawk Limited appoints Phil George as Chief Strategy Officer effective 1 June 2024.
- Phil George brings significant experience in U.S. Government and private sector risk, intelligence, and security.
- The CSO role will focus on strategic direction, capability expansion, and partnership growth, especially in the U.S.
- Key terms of Phil George’s executive services agreement have been disclosed, covering remuneration and incentives.
- WhiteHawk expects Mr. George’s leadership to drive growth and new commercial opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SKS Technologies Group Limited (SKS) ORDINARY FULLY PAID |
Industrials |
$1,069 |
SKS FY 25 Results Presentation
|
26 Aug 2025 9:38AM |
$2.680 |
$9.270 |
risen by
245.90%
|
|
SKS - Price-sensitive ASX Announcement
Full Release
Key Points
- SKS Technologies Group Limited reported strong revenue growth for FY23, with revenues of $103.7 million, up 28.5% from the previous year.
- EBITDA increased significantly by 85.2% to $5.6 million, with NPAT rising to $1.44 million, reflecting improved profitability.
- The company maintained a record order book of $143 million as of 30 June 2023, providing clear visibility into future revenue.
- Major project wins and completions included large defense and data centre contracts, particularly in the health and education sectors.
- Operational enhancements were made through investment in systems, processes, and management to support future growth and scalability.
- The company’s strategy focuses on high-growth, repeat revenue sectors, and leveraging its capabilities in advanced technology integration.
- Cash position and balance sheet remain strong, supporting ongoing investment and growth initiatives.
- Leadership expects continued momentum into FY24, supported by the robust project pipeline and strong market demand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Investors Mutual Concentrated Australian Share Fund (Quoted Managed Fund) (IMLC) |
Financials |
$3 |
Disclosure of Portfolio Holdings - June 2025
|
26 Aug 2025 9:38AM |
$4.520 |
$3.980 |
fallen by
11.95%
|
|
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$22 |
Notice of change of interests of substantial holder
|
26 Aug 2025 9:38AM |
$0.038 |
$0.090 |
risen by
136.84%
|
|
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$4 |
5EA - Form 8-K - Closing of Equtiy Offering
|
26 Aug 2025 9:37AM |
$0.560 |
$0.250 |
fallen by
55.36%
|
|
| SKS Technologies Group Limited (SKS) ORDINARY FULLY PAID |
Industrials |
$1,069 |
SKS FY25 Results Announcement
|
26 Aug 2025 9:37AM |
$2.680 |
$9.270 |
risen by
245.90%
|
|
SKS - Price-sensitive ASX Announcement
Full Release
Key Points
- SKS Technologies Group Limited released its FY25 results announcement.
- The company maintained steady revenues driven by technology integration and audio visual projects.
- SKS is involved in delivering complex solutions for commercial and infrastructure sectors.
- Recent contract wins and project deliveries have been highlighted.
- There is a strong pipeline and expansion into new market segments.
- Operational improvements and cost management initiatives are ongoing.
- The company is committed to sustainable growth and shareholder value.
- Management remains confident about achieving further growth in FY25.
- Strategic partnerships and continued innovation are key focus areas for SKS.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$40 |
Corporate Governance Statement 2025 and Appendix 4G
|
26 Aug 2025 9:36AM |
$0.265 |
$0.097 |
fallen by
63.40%
|
|
| EVT Limited (EVT) ORDINARY FULLY PAID |
Communication Services |
$2,101 |
Notification of cessation of securities - EVT
|
26 Aug 2025 9:36AM |
$14.620 |
$12.930 |
fallen by
11.56%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$7 |
FOS Investor webinar August 2025
|
26 Aug 2025 9:35AM |
$0.320 |
$0.100 |
fallen by
68.75%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$271,134 |
Issue of EUR 1,000,000,000 worth of Subordinated Notes
|
26 Aug 2025 9:35AM |
$170.300 |
$162.020 |
fallen by
4.86%
|
|
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$22 |
Application for quotation of securities - PL3
|
26 Aug 2025 9:35AM |
$0.038 |
$0.090 |
risen by
136.84%
|
|
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$746 |
Appendix 4G and Corporate Governance Statement
|
26 Aug 2025 9:35AM |
$2.720 |
$2.000 |
fallen by
26.47%
|
|
| 1414 Degrees Limited (14D) ORDINARY FULLY PAID |
Industrials |
$58 |
Notification of cessation of securities - 14D
|
26 Aug 2025 9:35AM |
$0.028 |
$0.096 |
risen by
242.86%
|
|
| Ai-Media Technologies Limited (AIM) ORDINARY FULLY PAID |
Industrials |
$45 |
Notice of Annual General Meeting/Proxy Form
|
26 Aug 2025 9:35AM |
$0.560 |
$0.215 |
fallen by
61.61%
|
|
| Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$53 |
ESR extends milestone timeline in key limestone partnership
|
26 Aug 2025 9:34AM |
$0.032 |
$0.024 |
fallen by
25%
|
|
ESR - Price-sensitive ASX Announcement
Full Release
Key Points
- Estrella Resources Limited (ESR) has announced an extension of the milestone timeline for its limestone partnership with Carbine Resources Limited.
- The extension relates to the Option and Joint Venture Agreement between ESR and Carbine over the Spargoville Project, specifically in relation to the exploration and development of limestone deposits.
- The new milestone date extends the timeframe in which Carbine may complete its required feasibility studies and earn a 51% interest in the Spargoville Limestone Project.
- The extension was made to allow Carbine additional time to complete due diligence and feasibility activities due to delays encountered in the project assessment.
- All other terms and conditions of the initial agreement between ESR and Carbine remain unchanged.
- ESR believes the partnership remains strategically important for the development of the Spargoville Limestone Project and for the company's overall growth strategy.
- The company will provide further updates to shareholders as material developments occur regarding the partnership and the progress of the limestone project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$44 |
Appendix 4E and 2025 Annual Report
|
26 Aug 2025 9:34AM |
$0.150 |
$0.058 |
fallen by
61.33%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon Therapeutics Limited (NUZ) released its Appendix 4E and 2025 annual report covering the year ended 31 December 2025.
- The company focuses on the development of therapies for neurological and neuropsychiatric disorders.
- Key clinical and research milestones are detailed, including updates on lead drug candidates and ongoing trials.
- Financial results include income statement, balance sheet, and cash flow statement with accompanying notes.
- The directors’ report provides governance, risk management, and strategic outlook information.
- Discussion of research and development expenditure and progress on the clinical pipeline.
- Auditor’s statement and independent auditor’s report are included, confirming compliance and transparency.
- Corporate governance disclosures detail the company’s regulatory adherence and board practices.
- The report outlines the company’s commitment to sustainability, compliance, and shareholder engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PolarX Limited (PXX) ORDINARY FULLY PAID |
Materials |
$38 |
Trading Halt
|
26 Aug 2025 9:34AM |
$0.018 |
$0.014 |
fallen by
22.22%
|
|
PXX - Price-sensitive ASX Announcement
Full Release
Key Points
- PolarX Limited (ASX:PXX) has requested a trading halt on its securities.
- The trading halt was effective from 20 June 2024.
- The halt is pending the release of an announcement to the market.
- Trading will resume at the earlier of normal trading on 24 June 2024 or the release of the announcement.
- The request was made under ASX Listing Rule 17.1.
- The trading halt is intended to ensure orderly management of the market.
- The Board of PolarX Limited approved the request.
- The announcement was authorised by Managing Director, Mr. Frazer Tabeart.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$98 |
Amendment to Kachi Phase One DFS Addendum Presentation
|
26 Aug 2025 9:33AM |
$0.032 |
$0.042 |
risen by
31.25%
|
|
LKE - Price-sensitive ASX Announcement
Full Release
Key Points
- Amendment to the Kachi Phase One DFS Addendum Presentation released by Lake Resources NL.
- Updated development schedule and revised capital/operating cost estimates for the Kachi Lithium Brine Project in Argentina.
- Incorporation of independent expert feedback and technical improvements.
- Optimized project design for improved sustainability and response to lithium market conditions.
- Key changes include adjusted production timelines and updated project financials (NPV and IRR).
- Continued stakeholder engagement, including local communities and regulators.
- Emphasis on environmental and social responsibility in project execution.
- Commitment to advancing the Kachi project using direct lithium extraction technology.
- Focus on project transparency, governance, and long-term value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$3,939 |
Statement of Changes in Beneficial Ownership
|
26 Aug 2025 9:33AM |
$122.290 |
$107.780 |
fallen by
11.87%
|
|
Call 1300 880 160
Start a chat
Schedule a call
